Sign In
Buy FMI
$137.00
+0 (+0%)
At Close: Sep 18, 2018
Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2015 Financial Results and Conference Call
06:30am, Thursday, 04'th Feb 2016
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2015, will be released on
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $26.1 million in the fourth quarter of 2015 and $93.2 million f
Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
06:30am, Tuesday, 13'th Oct 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2015, will be released on Tuesday,
Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
06:30am, Monday, 06'th Jul 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2015, will be released on Wednesday, Ju
Foundation Medicine Announces Timing for First Quarter 2015 Financial Results and Conference Call
06:30am, Tuesday, 14'th Apr 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2015 will be released on Monday, May 11
Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2014 Financial Results and Conference Call
06:30am, Tuesday, 03'rd Feb 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company’s fourth quarter and year ended December 31, 2014, will be released o
Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology
01:00am, Monday, 12'th Jan 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that they will enter into a broad strategic collaboration to further ad
Foundation Medicine Reports Preliminary 2014 Results
12:50am, Monday, 12'th Jan 2015
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $18.7 million in the fourth quarter of 2014 and $61.1 mil
Foundation Medicine Announces Timing for Third Quarter 2014 Financial Results and Conference Call
06:30am, Thursday, 16'th Oct 2014
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company’s third quarter ended September 30, 2014, will be released on Wednesd
